Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure

ESC Heart Fail. 2022 Dec;9(6):4077-4087. doi: 10.1002/ehf2.14083. Epub 2022 Aug 31.

Abstract

Aims: Given the various effects of sacubitril/valsartan in heart failure, a deeper understanding of atrial natriuretic peptide (ANP) actions is warranted. Natriuresis is a fundamental action of ANP in acute heart failure (AHF), whereas the diuretic effect of ANP is different in each patient according to the diversity of renal response to ANP, which is affected by baseline plasma ANP status and deficiency of circulating ANP. Meanwhile, associations between other neuroendocrine hormones and the diuretic response to ANP are unclear. This study investigated the impact of pivotal neuroendocrine hormones on the diuretic effects of exogenous ANP, carperitide.

Methods and results: Plasma ANP, renin, aldosterone, and vasopressin levels and the diuretic effect of 0.0125 μg/kg/min of carperitide alone for the first 6 h were prospectively evaluated in 75 patients with AHF. Lower ANP levels were significantly associated with a greater diuretic response to exogenous ANP (r = -0.35, P = 0.002). Additionally, higher vasopressin levels were significantly related to the poor diuretic effects of exogenous ANP (r = -0.54, P < 0.001). Plasma ANP and vasopressin concentrations were not significantly correlated (r = 0.19, P = 0.10). Baseline systolic blood pressure, renal function, and prior use of loop diuretics did not predict the diuretic response to exogenous ANP, whereas vasopressin levels independently predicted a diuretic response to exogenous ANP (P < 0.001), as well as lower plasma ANP levels (P = 0.027).

Conclusions: Vasopressin status was significantly associated with the diuretic response to exogenous ANP in AHF, independent of plasma ANP status. The results may provide a better understanding of the actions of sacubitril/valsartan.

Keywords: Acute heart failure; Atrial natriuretic peptide; Carperitide; Plasma osmolality; Vasopressin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Natriuretic Factor
  • Diuretics* / pharmacology
  • Diuretics* / therapeutic use
  • Heart Failure* / drug therapy
  • Humans
  • Neurosecretory Systems
  • Valsartan
  • Vasopressins

Substances

  • Atrial Natriuretic Factor
  • Diuretics
  • sacubitril
  • Valsartan
  • Vasopressins